Cargando…
A rare case of methimazole-induced cholestatic jaundice in an elderly man of Asian ethnicity with hyperthyroidism: A case report
BACKGROUND: Methimazole is an antithyroid drug that is widely used for the treatment of hyperthyroidism. As an inhibitor of the enzyme thyroperoxidase, methimazole is generally well-tolerated. However, there have been increasing reports of methimazole-induced liver damage, although this effect of me...
Autores principales: | Ji, Hongjian, Yue, Feng, Song, Jianxiang, Zhou, Xiaohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728948/ https://www.ncbi.nlm.nih.gov/pubmed/29245333 http://dx.doi.org/10.1097/MD.0000000000009093 |
Ejemplares similares
-
Case report: Severe cholestatic jaundice associated with hyperthyroidism treated with methimazole
por: Liu, Xiaoqiang, et al.
Publicado: (2023) -
A Case Report on Methimazole-Induced Cholestatic Jaundice in an Elderly Man With Hyperthyroidism
por: Ng, Jennifer Lourdes, et al.
Publicado: (2021) -
A rare case report of obstructive jaundice caused by mucus-producing cholangiocarcinoma
por: Duan, Botao, et al.
Publicado: (2022) -
Methimazole-induced cholestatic hepatitis: two cases report and literature review
por: Zou, Hai, et al.
Publicado: (2015) -
SUN-572 Hyperthyroidism Refractory to Methimazole
por: Eren, Aysegul, et al.
Publicado: (2019)